BE study: modified vs immediate release [Design Issues]

posted by BE-proff – 2015-07-28 21:15 (3987 d 07:26 ago) – Posting: # 15165
Views: 8,930

Dear All,

May be my question will seem stupid but nevertheless I ask it.
I have to demonstrate BE between modified release product (taken once a day) and immediate-release product (taken twice a day).
IMHO there is a risk that both product can show different kinetics and they won't be equivalent in 1-time administration of each medications.
To avoid this risk I think of steady state study.

But how to prove my idea based on actual guides?

Does anybody have such experience?

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
391 visitors (0 registered, 391 guests [including 28 identified bots]).
Forum time: 04:41 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5